What Researchers Did
This cohort study investigated the molecular changes induced by extracorporeal shockwave therapy (ESWT) versus hyperbaric oxygen therapy (HBOT) in chronic diabetic foot ulcers.
What They Found
After ESWT, significant increases were observed in vWF, VEGF, eNOS, PCNA, and EGF expressions, along with a decrease in TUNEL expression (P0.05). Post-treatment, ESWT demonstrated significantly greater increases in these markers compared to HBOT (P<0.05), indicating enhanced angiogenesis and tissue regeneration.
What This Means for Canadian Patients
Canadian patients with chronic diabetic foot ulcers might benefit from extracorporeal shockwave therapy as a potential treatment option. This therapy could promote better wound healing by stimulating angiogenesis and tissue regeneration, potentially reducing complications.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.
Study Limitations
The study's findings may be limited by its relatively small sample size and the specific patient population studied.